Overview

rhTPO in Critical Patients With Thrombocytopenia

Status:
Unknown status
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are to assess the impact of rhTPO on mortality among severe sepsis patients with thrombocytopenia, as well as changes of platelet counts and platelet transfusion rates.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Jinling Hospital, China